NIH-funded research R01 grant

Understanding Pain After Spinal Cord Injury

Official title: Exploring the EphB2-NMDA receptor interaction in spinal cord injury-induced neuropathic pain

Funded at Thomas Jefferson University · NIH-11143076 · Data updated 2026-11-12

This project looks at how certain brain signals contribute to long-lasting pain after a spinal cord injury, hoping to find new ways to help patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2018
Project endJune 30, 2029
Funding year2025
Award (this year)$606,261
NIH project number5R01NS110385-07
Project IDNIH-11143076 on NIH RePORTER

Who could benefit from this research

Could help

Patients experiencing chronic, difficult-to-treat neuropathic pain following a spinal cord injury are the focus of this research.

Less likely to help

Patients whose pain is not related to spinal cord injury or is not neuropathic in nature may not directly benefit from this specific research.

What this research studies

Many people experience severe, ongoing pain after a spinal cord injury that is very hard to treat. Our team is focusing on two specific brain signals, called EphB2 and NMDA receptors, and how they work together in the spinal cord's pain pathways. We believe that by understanding how these signals interact and cause nerve cells to become overactive, we can uncover new ways to calm this pain. This work aims to identify new targets for treatments that could offer relief without relying on opioids.

Why it matters

Potential benefit: If successful, this work could lead to new, more effective treatments for the chronic, severe pain that often follows a spinal cord injury.

How similar studies have gone: This project builds on the team's own discoveries about the specific mechanism of interaction between EphB2 and NMDA receptors, suggesting a novel approach.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Lepore, Angelo C. — Thomas Jefferson University
  • Study coordinator: Lepore, Angelo C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.